Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Ramy Mohamed Ghazy, Abdallah Almaghraby, Ramy Shaaban, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Andrew Hill, Anna Garratt, Jacob Levi, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 11
Open Access | Times Cited: 68
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Guang Lu, Yu Wang, Yin Shi, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 62
Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling
Gaetano Zizzo, Antonio Tamburello, Laura Castelnovo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Autophagy-Inflammation Interplay During Infection: Balancing Pathogen Clearance and Host Inflammation
Yuqian Pang, Lanxi Wu, Cheng Tang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 39
Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials
Ahmed Kamel, Mona S. Abdel Monem, Nour A. Sharaf, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Open Access | Times Cited: 49
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
Hannah R. Mathew, May Y. Choi, Michael D. Parkins, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Isaltino Pereira De Andrade, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Hydroxychloroquine Adsorption in Aqueous Medium Using Clinoptilolite Zeolite
Ramiro Picoli Nippes, Paula Derksen Macruz, Luiza Carla Augusto Molina, et al.
Water Air & Soil Pollution (2022) Vol. 233, Iss. 8
Open Access | Times Cited: 33
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 30
On the Origin of Neutrophil Extracellular Traps in COVID-19
Michal Pastorek, M Dúbrava, Peter Celec
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
Manaf AlQahtani, Nitya Kumar, Dhuha Aljawder, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Cenário epidemiológico, estrutural e espacial da ocorrência de Covid-19 em uma região de saúde, na Amazônia brasileira
Edlainny Araujo Ribeiro, Alex Nicolella, Ulisses Viana Mourão Sobrinho
Revista de Ciências Médicas e Biológicas (2025) Vol. 23, Iss. 3
Open Access
The equivocal healthcare market in Bangladesh during the COVID‐19 pandemic: Policy, politics and life
Nur Newaz Khan
The Australian Journal of Anthropology (2025)
Closed Access
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
Stav Rakedzon, Ami Neuberger, Abraham J. Domb, et al.
Journal of Travel Medicine (2021) Vol. 28, Iss. 2
Open Access | Times Cited: 39
Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
Decsa Medika Hertanto, Bayu Satria Wiratama, Henry Sutanto, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3419-3428
Open Access | Times Cited: 33
RETRACTED: Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish
Juliana Moreira Mendonça-Gomes, Amanda Pereira da Costa Araújo, Thiarlen Marinho da Luz, et al.
The Science of The Total Environment (2021) Vol. 790, pp. 148129-148129
Open Access | Times Cited: 33
Coronavirus disease 2019 (COVID-19) and autoimmunity
Е. Л. Насонов
Rheumatology Science and Practice (2021) Vol. 59, Iss. 1, pp. 5-30
Open Access | Times Cited: 32
Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients
Lucas Barbosa Oliveira, Victor Irungu Mwangi, Marco Aurélio Sartim, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 21
Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
Weifeng He, Yuan Gao, Jing Zhou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4690-4703
Open Access | Times Cited: 21
Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, et al.
Future Virology (2021) Vol. 17, Iss. 2, pp. 95-118
Open Access | Times Cited: 24
Mouthrinses and SARS-CoV-2 viral load in saliva: a living systematic review
Akram Hernández‐Vásquez, Antonio Barrenechea-Pulache, Daniel Comandé, et al.
Evidence-Based Dentistry (2022)
Open Access | Times Cited: 18
A deep learning semantic segmentation architecture for COVID‐19 lesions discovery in limited chest CT datasets
Nour Eldeen M. Khalifa, Gunasekaran Manogaran, Mohamed Hamed N. Taha, et al.
Expert Systems (2021) Vol. 39, Iss. 6
Open Access | Times Cited: 22
Applying polypharmacology approach for drug repurposing for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Journal of Chemical Sciences (2022) Vol. 134, Iss. 2
Open Access | Times Cited: 14
Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study
Marta Entrenas Castillo, Luis Manuel Entrenas Costa, María P. Pata, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top